1-3 of 3
Paula Rodriguez, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Locommotion Study (MMY4001): A Prospective, Multinational Study of Real-Life Current Standards of Care in Patients with Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including PI, IMiD, and CD38 Monoclonal Antibody Treatment and Documented Disease Progression

Michel Delforge, MD PhD, Philippe Moreau, MD, Maria-Victoria Mateos, Valerio De Stefano, MD, Katja Weisel, Jesús San-Miguel, Hermann Einsele, MD, Thierry Facon, MD, Mario Boccadoro, Hartmut Goldschmidt, Michele Cavo, Laura Rosinol, MD PhD, Martin F. Kaiser, Francesca Gay, MD, Christof Scheid, MD, Annemiek Broyl, MD PhD, Niels W. C. J. Van De Donk, MD PhD, Paula Rodriguez, MD, Anna Potamianou, Caline Sakabedoyan, Vadim Strulev, Tonia Nesheiwat, Paul Bergmans, Syed Rizvi, MD, Arkadiusz Pilatowicz, Pieter Sonneveld
Journal: Blood
Blood (2019) 134 (Supplement_1): 5549.
https://doi.org/10.1182/blood-2019-122939
Published: 2019
Journal Articles

Circulating Tumor Cells (CTCs) for Comprehensive and Multiregional Non-Invasive Genetic Characterization of Multiple Myeloma (MM)

Juan José Garcés, Gabriel Bretones, Leire Burgos, Rafael Valdes-Mas, Diego Alignani, PhD, Diana Álvarez Puente, Ibai Goicoechea, PhD, Miguel García Álvarez, Sonia Garate, Idoia Rodriguez, Maria Jose Calasanz, PhD BSc, Paula Rodriguez, MD, Rafael Rios, MD PhD, Joaquin Martinez-Lopez, MD PhD, Pamela Millacoy, Luis Palomera, MD PhD, Rafael Del Orbe, MD PhD, Albert Pérez, MD, Xabier Agirre, PhD, Juan Flores-Montero, Luzalba Sanoja-Flores, Alberto Orfao, MD PhD, Halima El Omri, Felipe Prosper, MD PhD, Carlos Lopez-Otin, Jesús San-Miguel, Bruno Paiva, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3064.
https://doi.org/10.1182/blood-2019-126527
Published: 2019
Journal Articles

Melflufen Therapy for Relapsed Refractory Multiple Myeloma (RRMM) Patients Refractory to Daratumumab and/or Pomalidomide: A Report on Early Efficacy

Maria-Victoria Mateos, MD, Joan Bladé, MD PhD, Alessandra Larocca, Albert Oriol, MD, Paula Rodriguez, MD, Adrián Alegre, MD, Michele Cavo, MD, Jan S Moreb, MD, Agne Paner, MD, Nashat Gabrail, MD, Kathleen G. Halka, MD, Hani Hassoun, MD, Christopher Maisel, MD, Amitabha Mazumder, MD, Jeffrey A Zonder, MD, Enrique M Ocio, MD, Catriona Byrne, RN, Johan Harmenberg, MD PhD, Sara Thuresson, MSc, Eva Nordstrom, MSc, MBA, Jakob Lindberg, MD PhD, Paul G Richardson, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1841.
https://doi.org/10.1182/blood.V130.Suppl_1.1841.1841
Published: 2017